Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02345811 · ClinicalTrials.gov registry record · NA
A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT02345811 is a NA study that has completed, run by CooperVision. The registered enrollment target is 34 participants.
The verdict
NCT02345811, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.
Interventions
- DEVICE senofilcon A
- DEVICE Sapphire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02345811
The ClinicalTrials.gov registry entry for NCT02345811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.
NCT02345811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02345811 about?
NCT02345811 is a clinical study titled "A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks". To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.
What is the current status of trial NCT02345811?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2015-01. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02345811?
The interventions under investigation include: senofilcon A (DEVICE), Sapphire (DEVICE).
Who is sponsoring clinical trial NCT02345811?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.